Invesco BulletShares 2030 Corporate Bond ETF (NASDAQ: BSCU)

에 대한 최신 뉴스 Invesco BulletShares 2030 Corporate Bond ETF (NASDAQ:BSCU)

The Fund generally will invest at least 80 percent of its total assets in securities that comprise the Underlying Index. Strictly in accordance with its guidelines and mandated procedures, Invesco Indexing LLC (the Index Provider) compiles and maintains the Underlying Index. The Underlying Index seeks to measure the performance of a portfolio of U.S. dollar-denominated investment grade corporate bonds with maturities or, in some cases, effective maturities in the year 2030 (collectively, 2030 Bonds). Certain bonds in which the Fund may invest may contain embedded issuer call options. An embedded issuer call option means that the bonds issuer has the right to redeem a bond prior to its designated maturity date. Accordingly, the effective maturity date of a bond reflects an assessment of when that bond is likely to be called by the issuer, or in the alternate, the bonds stated maturity date (if it is not called by the issuer).

Invesco BulletShares 2030 Corporate Bond ETF

Needham analyst Quinn Bolton reiterates Silicon Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) with a Buy and maintains $150 price target.

News

Price Target

Reiteration

Analyst Ratings

SLAB

Needham Reiterates Buy on Silicon Laboratories, Maintains $150 Price Target

Earnings

Earnings Misses

LDTC

LeddarTech Holdings Q2 EPS $(0.42) Misses $(0.39) Estimate

Septerna, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEPN#NASDAQ">SEPN</a>) and Novo Nordisk today announced an exclusive global collaboration and license agreement to discover, develop and commercialise oral small molecule medicines for obesity, type 2 diabetes and other cardiometabolic diseases.
The companies will initially commence four development programmes for potential small molecule therapies directed to one or more select G protein-coupled receptor (GPCR) targets, including the GLP-1, GIP and glucagon receptors.
&nbsp;
<ul>
<li>Septerna is eligible to receive approximately 2.2 billion US dollars, including more than 200 million dollars in upfront and near-term payments</li>
</ul>

SEPN

Septerna and Novo Nordisk to collaborate on oral small molecule medicines for obesity and other cardiometabolic diseases

Biotech

General

KTTA

Pasithea Therapeutics Initiates Phase 1/1B Study Of PAS-004 In Adult NF1 Patients, First Patient Expected To Be Dosed In Q2 2025

Boralex (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BLX#TSX">BLX</a>) reported quarterly earnings of $0.29 per share which missed the analyst consensus estimate of $0.37 by 21.62 percent. This is a 45.28 percent decrease over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $226.00 million which missed the analyst consensus estimate of $242.70 million by 6.88 percent. This is a 12.74 percent decrease over sales of $259.00 million the same period last year.

TSX:BLX

Boralex Q1 EPS $0.29 Misses $0.37 Estimate, Sales $226.00M Miss $242.70M Estimate

Centessa Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTA#NASDAQ">CNTA</a>) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.37) by 45.95 percent. This is a 47.37 percent increase over losses of $(0.38) per share from the same period last year. The company reported $15.00 million in sales this quarter.

Earnings Beats

CNTA

Centessa Pharmaceuticals Q1 EPS $(0.20) Beats $(0.37) Estimate, Sales $15.00M

Telsey Advisory Group analyst Cristina Fernandez maintains On Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) with a Outperform and maintains $65 price target.

ONON

Telsey Advisory Group Maintains Outperform on On Holding, Maintains $65 Price Target

Business Outlook Tower Semiconductor guides revenues for the second quarter of 2025 to be $372 million, with an upward or downward range of 5%, reflecting 6% year-over-year revenue increase; and reiterates its previously communicated company target for continued quarter-over-quarter revenue growth within 2025.

Guidance

TSEM

Tower Semiconductor Sees Q2 Sales $353.400M-$390.600M vs $371.26M Est

GLBE

Global E Online Affirms FY2025 Sales Guidance of $917.00M-$967.00M vs $931.39M Est

INVE

Identiv Introduces A New Nfc-based Anti-counterfeiting Smart Packaging Solution For Luxury Wine Producers And Collectors In Collaboration With Zatap And Genuine-analytics

LeddarTech Launches LeddarSim Simulation Platform To Bridge Gap Between Virtual Testing And Real-World Deployment In ADAS And Autonomous Driving

Global E Online Sees Q2 Sales $204.000M-$211.000M vs $209.63M Est

With U.S. stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
<ul class="wp-block-list">
<li>Sony Group Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) reported quarterly earnings of 21 cents per share on sales of $17.25 billion, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Sony shares fell 0.6% to $24.40 in after-hours trading.</li>
<li>American Eagle Outfitters Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEO#NYSE">AEO</a>) reported preliminary results for the first quarter and withdrew its full-year guidance. After the market close on Tuesday, American Eagle said in a filing that it expects to report first-quarter revenue of $1.1 billion, representing a decline of 5% year-over-year. American Eagle shares dipped 13.5% to $11.00 in the after-hours trading session.</li>
<li>Analysts are expecting Cisco Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) to post quarterly earnings at 92 cents per share on revenue of $14.05 billion. The company will release earnings after the markets close. Cisco shares gained 0.2% to $61.91 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul class="wp-block-list">
<li>Alcon Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALC#NYSE">ALC</a>) posted downbeat results for the first quarter on Tuesday. The company lowered its FY2025 earnings guidance, but raised its sales guidance. Alcon shares fell 2.4% to $91.00 in the after-hours trading.</li>
<li>Analysts expect MakeMyTrip Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) to report quarterly earnings at 30 cents per share on revenue of $255.93 million before the opening bell. MakeMyTrip shares rose 0.2% to $106.75 in after-hours trading.</li>
</ul>
Check This Out: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45375319/jim-cramer-ok-harrow-recommends-buying-this-energy-stock">Jim Cramer Is &#8216;OK&#8217; With Harrow, Recommends Buying This Energy Stock</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Markets

Trading Ideas

CSCO

MMYT

Sony Group Corporation American Depositary Shares

SONY

American Eagle, Cisco Systems And 3 Stocks To Watch Heading Into Wednesday

Innoviz Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVZ#NASDAQ">INVZ</a>) affirms FY2025 sales outlook from $50.00 million-$60.00 million to $50.00 million-$60.00 million vs $54.75 million estimate.

INVZ

Innoviz Technologies Affirms FY2025 Sales Guidance of $50.00M-$60.00M vs $54.75M Est

Chicago Atlantic BDC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIEN#NASDAQ">LIEN</a>) reported quarterly earnings of $0.34 per share which met the analyst consensus estimate. This is a 3500 percent increase over losses of $(0.01) per share from the same period last year.

LIEN

Chicago Atlantic BDC Q1 EPS $0.34, Inline

Health Care

PYPD

PolyPid Had Cash And Cash Equivalents And Short-term Deposits Of $8M, As of March 31, 2025, That Is Expected To Provide Cash Runway Into Q3 Of 2025

Cellebrite DI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLBT#NASDAQ">CLBT</a>) sees Q2 sales of $110.000 million-$116.000 million vs $115.34 million analyst estimate.

CLBT

Cellebrite DI Sees Q2 Sales $110.000M-$116.000M vs $115.34M Est

BCRX

BioCryst Announces FDA Acceptance Of Its New Drug Application For Oral, Once Daily ORLADEYO In Hereditary Angioedema Patents Aged 2 To 11 Years

Cellebrite DI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLBT#NASDAQ">CLBT</a>) lowers FY2025 sales outlook from $480.00 million-$490.00 million to $470.00 million-$485.00 million vs $484.17 million estimate.

Cellebrite DI Lowers FY2025 Sales Guidance from $480.00M-$490.00M to $470.00M-$485.00M vs $484.17M Est

The CNN Money Fear and Greed index showed further improvement in the overall market sentiment, while the index remained in the &#8220;Greed&#8221; zone on Tuesday.
U.S. stocks settled mixed on Tuesday, with the Nasdaq Composite jumping around 300 points during the session. The U.S. and China agreed to a 90-day truce by slashing triple-digit tariffs effective May 14.
The Consumer Price Index showed signs of cooling in April, as both headline and core readings eased or met expectations, easing concerns that Trump&#8217;s proposed trade tariffs would trigger a surge in inflation.
Shares of NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) jumped around 5.6% on Tuesday as the company announced a strategic partnership with HUMAIN aimed at establishing Saudi Arabia as a leader in artificial intelligence (AI) and GPU cloud computing. UnitedHealth Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) shares tumbled around 18% after the company announced it suspended its FY25 guidance and announced the appointment of Stephen Hemsley as CEO.
Most sectors on the S&amp;P 500 closed on a negative note, with health care, consumer staples and real estate stocks recording biggest losses on Tuesday. However, information technology and consumer discretionary stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 270 points to 42,140.43 on Tuesday. The S&amp;P 500 surged 0.72% to 5,886.55, while the Nasdaq Composite jumped 1.61% at 19,010.08 during Tuesday's session.
Investors are awaiting earnings results from Sony Group Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>), Cisco Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) and MakeMyTrip Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) today.
At a current reading of 68.7, the index remained in the &#8220;Greed&#8221; zone on Tuesday, versus a prior reading of 66.5.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based
&nbsp;on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45375319/jim-cramer-ok-harrow-recommends-buying-this-energy-stock">Jim Cramer Is &#8216;OK&#8217; With Harrow, Recommends Buying This Energy Stock</a> </li>
</ul>
Photo via Shutterstock

Comments

Invesco BulletShares 2030 Corporate Bond ETF

뉴스

에 대한 최신 뉴스 Invesco BulletShares 2030 Corporate Bond ETF (NASDAQ:BSCU)

뉴스

파트너 / 기고자

벤징가 글로벌